Les infections urinaires (IU) touchent plus de 150 millions de personnes dans le monde chaque année, ce qui en fait l'une des infections bactériennes les plus fréquentes en pratique clinique. Elles vont de l'IU basse non compliquée (cystite) chez des femmes en bonne santé par ailleurs, aux infections graves des voies urinaires hautes (pyélonéphrite) et aux infections associées aux cathéters nécessitant une hospitalisation. Ce guide couvre le spectre clinique des infections urinaires — notamment les causes, le diagnostic, les protocoles de traitement antibiotique et la prévention — avec des recommandations cliniques fondées sur les lignes directrices EAU et IDSA.
What is a Urinary Tract Infection?
A urinary tract infection (UTI) is an infection that affects any part of the urinary system — including the kidneys, ureters, bladder, and urethra. Most infections involve the lower urinary tract, primarily the bladder and the urethra.
UTIs are among the most common bacterial infections in the world. While they can affect anyone, women are significantly more susceptible due to their shorter urethra, which allows bacteria to reach the bladder more easily.
When to see a doctor
If you experience burning urination, pelvic pain, cloudy urine, or a persistent urge to urinate, consult a healthcare professional. Untreated UTIs can spread to the kidneys.
Urinary tract infections represent a spectrum of conditions ranging from uncomplicated cystitis in healthy premenopausal women to complex urosepsis in catheterized, immunocompromised, or structurally abnormal patients. Classification is critical for guiding empirical therapy.
| Classification | Definition | Key Considerations |
|---|---|---|
| Uncomplicated UTI | Lower UTI in non-pregnant women without structural/functional abnormalities | Short-course antibiotics; no imaging required |
| Complicated UTI | Any UTI associated with functional/structural urinary tract abnormality, or in special populations (men, pregnant women, immunocompromised, catheterized patients) | Urine culture mandatory; longer treatment course |
| Recurrent UTI | ≥3 episodes per year or ≥2 episodes in 6 months | Investigate underlying cause; consider prophylaxis |
| Catheter-associated UTI (CAUTI) | UTI in patients with urinary catheter in place for >2 days | Remove catheter if possible; distinct antibiogram |
| Asymptomatic Bacteriuria | ≥10⁵ CFU/mL on 2 consecutive specimens without symptoms | Treatment only in pregnancy and pre-urological procedures |
Anatomy of the Urinary Tract
Kidneys
Filter blood, produce urine. Kidney infections (pyelonephritis) are serious and require prompt treatment.
Ureters
Tubes carrying urine from kidneys to bladder. Can be affected by stones or strictures.
Bladder
Stores urine. Cystitis (bladder infection) is the most common UTI form.
Urethra
Carries urine outside the body. Urethritis often presents with discharge and burning.
Clinical Note — Ascending Infection Pathway
The most common route of infection is ascending, with periurethral colonization by uropathogens (predominantly E. coli expressing type 1 and P fimbriae) followed by bladder invasion. Vesico-ureteral reflux (VUR), bladder outlet obstruction, ureteral stenting, and nephrostomy access all create conditions that promote retrograde ascent into the upper urinary tract. The female urethra (3–4 cm) versus the male (20 cm) accounts for the marked sex disparity in uncomplicated UTI incidence.
Causes & Risk Factors
UTIs are most commonly caused by bacteria from the gut, particularly Escherichia coli (E. coli), which accounts for around 80–85% of cases. These bacteria can enter the urinary tract and multiply rapidly.
| Pathogen | Frequency | Key Notes |
|---|---|---|
| Escherichia coli | 80–85% | Virulence factors: fimbriae, hemolysin, cytotoxic necrotizing factor |
| Staphylococcus saprophyticus | 5–15% (young women) | Novobiocin-resistant; seasonal peaks in summer/autumn |
| Klebsiella pneumoniae | 5–8% | Emerging ESBL producers; nosocomial setting |
| Proteus mirabilis | 2–5% | Urease-producer; associated with struvite stones |
| Pseudomonas aeruginosa | <3% | Predominantly nosocomial/catheter-associated; high resistance rates |
| Enterococcus faecalis | <5% | Post-urological procedure; consider VRE in hospital settings |
Risk Factors
Signs & Symptoms
Lower UTI (Cystitis / Urethritis)
- Burning or painful urination (dysuria)
- Frequent, urgent need to urinate
- Passing only small amounts of urine
- Cloudy, dark, or strong-smelling urine
- Blood in urine (haematuria)
- Pelvic pressure or discomfort
Upper UTI (Pyelonephritis) ⚠️
- Fever and chills
- Flank, back, or side pain
- Nausea and vomiting
- High temperature (>38°C / 100.4°F)
- Costovertebral angle tenderness
- Requires immediate medical care
Clinical Pearl — Atypical Presentations
Elderly patients (especially those with dementia or delirium) and immunocompromised individuals frequently lack classic dysuria/frequency, presenting instead with unexplained delirium, falls, or haemodynamic instability. Catheterized patients may be asymptomatic or present only with suprapubic discomfort. Overdiagnosis of UTI in the elderly (attributing delirium to UTI without meeting formal NHSN/IDSA criteria) is a recognised quality metric and contributes to unnecessary antibiotic exposure.
Diagnosis
Your doctor will likely ask about your symptoms and request a urine sample. A dipstick test can detect signs of infection quickly, while a urine culture identifies the specific bacteria involved and guides antibiotic selection.
Symptom Assessment
Medical history & physical exam
Urinalysis
Dipstick + microscopy
Urine Culture
Identifies organism & sensitivity
Urinalysis Interpretation
- Leukocyte esterase: Sensitivity 75–96%; specificity 94–98%. Positive suggests pyuria (>5 WBC/hpf)
- Nitrites: Specificity ~95%; sensitivity ~50%. Only gram-negative Enterobacteriaceae reduce nitrates
- Combined LE + nitrite: Best discriminator in uncomplicated cystitis; negative dipstick has high NPV to exclude UTI
- Microscopy: Pyuria threshold: ≥10 WBC/mm³ on uncentrifuged specimen; bacteriuria: ≥10²–10⁵ CFU/mL depending on context
Imaging Indications
- Ultrasound: First-line for suspected obstruction, abscess, or paediatric UTI
- CT urogram: Diagnostic standard for pyelonephritis complications (abscess, emphysematous pyelonephritis), nephrolithiasis
- VCUG/MAG3: Evaluate vesico-ureteral reflux in paediatric recurrent UTI
- Cystoscopy: Recurrent haematuria, suspected bladder lesion, or structural abnormality
Traitement des infections urinaires : antibiotiques, hydratation et prise en charge des récidives
Most UTIs are effectively treated with a short course of oral antibiotics. It's important to complete the full course even if symptoms improve early. Your doctor will choose the antibiotic based on the bacteria identified and local resistance patterns.
Important: Never self-medicate
Using the wrong antibiotic or stopping treatment early contributes to antibiotic resistance and may not cure the infection. Always follow your doctor's prescription.
| UTI Type | First-Line (EAU/IDSA) | Duration | Notes |
|---|---|---|---|
| Uncomplicated Cystitis | Nitrofurantoin, Fosfomycin, Pivmecillinam | 3–5 days | Avoid fluoroquinolones as first-line; preserve for complicated UTI |
| Uncomplicated Pyelonephritis (mild) | Ciprofloxacin (if local resistance <10%) or TMP-SMX guided by cultures | 7–14 days | Culture before starting; adjust to sensitivity results |
| Complicated UTI / Hospitalised Pyelonephritis | IV ceftriaxone or piperacillin-tazobactam (initial empirical) | 10–14 days (step-down oral when appropriate) | Blood cultures; urology consult if obstruction suspected |
| CAUTI | Per local antibiogram; remove/replace catheter | 7 days (14 days if slow response) | Do not treat asymptomatic bacteriuria in catheterized patients |
| Recurrent UTI (prophylaxis) | Nitrofurantoin 50mg nocte or post-coital, D-mannose, intravaginal oestrogens (post-menopausal) | 3–6 months | Exclude anatomical cause first; review after 6 months |
💧 Hydration
Drinking plenty of water helps flush bacteria from the urinary tract. Aim for 1.5–2 litres daily, more during hot weather or fever.
🌿 Symptom Relief
Paracetamol or ibuprofen may help with discomfort. Some patients find urinary alkalinising agents (e.g. potassium citrate) soothing, though evidence is limited.
Prevention
Stay well hydrated
Adequate fluid intake dilutes urine and encourages frequent voiding, reducing bacterial colonisation time in the bladder.
Wipe front to back
This prevents transfer of gut bacteria from the anal area to the urethra — a simple but highly effective hygiene practice.
Urinate after sexual intercourse
Voiding after sex helps flush bacteria that may have been introduced into the urethra during sexual activity.
Avoid irritating products
Perfumed soaps, douches, and deodorant sprays near the genital area can disrupt natural flora and increase infection risk.
Cranberry products & D-Mannose
Some evidence supports the use of cranberry extract (PACs) and D-Mannose supplements in reducing recurrent UTIs by inhibiting bacterial adhesion to the urothelium.
Manage underlying conditions
Good glycaemic control in diabetes, prompt treatment of urinary obstruction, and minimising unnecessary catheterisation all reduce UTI risk significantly.
Clinical Insights & Current Guidelines
EAU 2024 Urological Infections Guidelines — Key Updates
- • Fluoroquinolones are no longer recommended as empirical first-line therapy for uncomplicated cystitis due to ecological collateral damage and resistance pressure.
- • Fosfomycin trometamol (3g single dose) remains a preferred option for uncomplicated cystitis with favourable resistance profile.
- • Post-procedural antibiotic prophylaxis (e.g. ureterorenoscopy, PCNL) is recommended only when pre-operative urine culture is positive or contamination risk is high.
- • Catheter-associated bacteriuria: treat only if symptomatic, pregnant, or prior to urological instrumentation.
Antimicrobial Stewardship Considerations
- • Reserve carbapenems for documented ESBL/carbapenem-susceptible organisms; meropenem for KPC/NDM-producing Enterobacteriaceae only if no alternative.
- • Urine cultures from catheterised patients frequently represent colonisation — clinical context is paramount.
- • Repeated quinolone exposure promotes fluoroquinolone-resistant E. coli and MRSA — consider resistance monitoring in high-risk populations.
Urological Device Considerations
Ureteral access sheaths (UAS), nephrostomy drainage catheters, and JJ stents all represent foreign body surfaces that predispose to biofilm formation. Continuous suction sheaths (e.g. Manawa FANS series) reduce intra-renal pressure build-up during ureteroscopy, potentially lowering pyelovenous backflow and infectious complications. Appropriate antibiotic prophylaxis before endourological procedures and timely removal of drainage devices remain the cornerstones of post-procedural UTI prevention.
Questions fréquentes : Infections urinaires
Quels sont les principaux symptômes d'une infection urinaire ?
Les symptômes les plus courants d'une IU basse (cystite) sont : brûlures ou douleurs à la miction (dysurie), envies fréquentes et urgentes d'uriner, urines troubles ou malodorantes, et pression pelvienne. L'IU haute (pyélonéphrite) entraîne des symptômes supplémentaires : fièvre supérieure à 38°C, frissons, douleurs lombaires, nausées et vomissements. La pyélonéphrite nécessite une attention médicale immédiate.
Comment traite-t-on une infection urinaire ?
La plupart des IU non compliquées sont traitées par une cure courte d'antibiotiques oraux de 3 à 5 jours. Les directives EAU actuelles recommandent en première intention la nitrofurantoïne, la fosfomycine ou la pivmécillinam. Les fluoroquinolones doivent être évitées en première ligne en raison des problèmes de résistance. Les IU compliquées ou hautes peuvent nécessiter 7 à 14 jours de traitement, et une pyélonéphrite sévère peut nécessiter des antibiotiques intraveineux et une hospitalisation.
Qu'est-ce qui provoque les infections urinaires récidivantes ?
Les infections urinaires récidivantes (3 épisodes ou plus par an) sont plus fréquentes chez la femme en raison de facteurs anatomiques. Les causes courantes incluent l'activité sexuelle, la ménopause, la vidange incomplète de la vessie, les calculs rénaux, les sténoses urétérales et l'utilisation prolongée de cathéters urinaires. Le traitement comprend le traitement de la cause sous-jacente, les antibiotiques prophylactiques à faible dose, la supplémentation en D-mannose ou les œstrogènes intravaginaux chez les femmes ménopausées.
Quelle est la différence entre cystite et pyélonéphrite ?
La cystite est une infection de la vessie (voies urinaires basses) provoquant dysurie, urgences et pollakiurie sans fièvre. La pyélonéphrite est une infection rénale (voies urinaires hautes) plus grave — se manifestant par de la fièvre, des douleurs lombaires, des nausées et une atteinte systémique. La pyélonéphrite nécessite un traitement antibiotique rapide et éventuellement une hospitalisation, en particulier chez les femmes enceintes, les personnes âgées ou immunodéprimées.
Comment prévenir les infections urinaires ?
Les principales stratégies de prévention comprennent : s'hydrater suffisamment (1,5 à 2 litres d'eau par jour), uriner après les rapports sexuels, s'essuyer de l'avant vers l'arrière après être allé aux toilettes, éviter les produits parfumés à proximité des organes génitaux, et traiter les affections sous-jacentes comme le diabète ou l'obstruction urinaire. Les extraits de canneberge (PAC) et les compléments de D-mannose ont une certaine efficacité prouvée pour réduire les récidives.